Skip to main content

Advertisement

Table 2 Proportions of patients with cardiovascular events before initiation of treatment and during follow-up and the rates (per 1000 person years) along with 95% confidence intervals of cardiovascular events, by treatment groups

From: The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

   Insulin EBID EBID + Insulin
   Previous Current Previous Current Previous Current
HF N (%) 901 (3.16) 2094 (7.33) 48 (1.71) 49 (1.75) 191 (2.43) 195 (2.48)
  Rate (CI) - 17.87 (17.00, 18.78) - 4.38 (3.17, 6.05) - 6.13 (5.30, 7.07)
MI N (%) 286 (1.00) 312 (1.09) 22 (0.78) 14 (0.50) 73 (0.93) 39 (0.50)
  Rate (CI) - 2.54 (2.23, 2.89) - 1.06 (0.55, 2.03) - 1.15 (0.82, 1.60)
Stroke N (%) 351 (1.23) 803 (2.81) 14 (0.50) 26 (0.93) 82 (1.04) 62 (0.79)
  Rate (CI) - 6.12 (5.62, 6.65) - 2.35 (1.52, 3.64) - 1.84 (1.41, 2.39)
MI or Stroke N (%) 620 (2.17) 1087 (3.81) 36 (1.28) 40 (1.43) 150 (1.91) 99 (1.26)
  Rate (CI)   8.50 (7.92, 9.13)   3.42 (2.38, 3.60)   2.93 (2.38, 3.60)
  1. Previous: Event prior to the index date, Current: Event after the index date.